Mesenchymal stem cell survival in the infarcted heart is enhanced by lentivirus vector-mediated heat shock protein 27 expression

Human Gene Therapy

Volumn 24, Issue 10, 2013, Pages 840-851

  McGinley, Lisa M ^a,b   McMahon, Jill ^a   Stocca, Alessia ^a,b   Duffy, Aoife ^a,b   Flynn, Aidan ^a,b   O'Toole, Daniel ^a   O'Brien, Timothy ^a,b  

^a NATIONAL UNIVERSITY OF IRELAND   (Ireland)

^b UNIVERSITY HOSPITAL GALWAY   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

HEAT SHOCK PROTEIN 27; LENTIVIRUS VECTOR;

ADIPOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CELL SURVIVAL; DNA MODIFICATION; FEMALE; HEART FUNCTION; HEART INFARCTION; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MALE; MESENCHYMAL STEM CELL; NICK END LABELING; NONHUMAN; PROTEIN EXPRESSION; RAT;

ANIMALS; APOPTOSIS; CELL DIFFERENTIATION; CELL SURVIVAL; DISEASE MODELS, ANIMAL; GENE EXPRESSION; GENETIC THERAPY; GENETIC VECTORS; HSP27 HEAT-SHOCK PROTEINS; HUMANS; LENTIVIRUS; MALE; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMAL CELLS; MYOCARDIAL INFARCTION; RATS; TRANSDUCTION, GENETIC; TRANSGENES;

EID: 84885394905     PISSN: 10430342     EISSN: 15577422     Source Type: Journal    
DOI: 10.1089/hum.2011.009     Document Type: Article

References (47)

1. Amado, L.C., et al. (2005). Cardiac repair with intramyocardial injection of allogeneic mesenchymal stem cells after myocar-dial infarction. Proc. Natl. Acad. Sci. USA 102, 11474-11479.
2. Assmus, B., et al. (2006). Transcoronary transplantation of progenitor cells after myocardial infarction. N. Engl. J. Med. 355, 1222-1232.
3. Bruey, J.M., et al. (2000). Hsp27 negatively regulates cell death by interacting with cytochrome c. Nat. Cell. Biol. 2, 645-652.
4. Chang, W., et al. (2009). Mesenchymal stem cells pretreated with delivered Hph-1-Hsp70 protein are protected from hypoxia-mediated cell death and rescue heart functions from myocar-dial injury. Stem Cells 27, 2283-2292.
5. Charette, S.J., et al. (2000). Inhibition of Daxx-mediated apoptosis by heat shock protein 27. Mol. Cell Biol. 20, 7602-7612.
6. Cheng, Z., et al. (2008). Targeted migration of mesenchymal stem cells modified with CXCR4 gene to infarcted myocardium improves cardiac performance. Mol. Ther. 16, 571-579.
7. Dai, W., et al. (2005). Allogeneic mesenchymal stem cell transplantation in postinfarcted rat myocardium: short-and longterm effects. Circulation 112, 214-223.
8. Elsasser, A., et al. (2001). The role of apoptosis in myocardial ischemia: a critical appraisal. Basic Res. Cardiol. 96, 219-226.
9. George, J.C. (2010). Stem cell therapy in acute myocardial infarction: a review of clinical trials. Transl. Res. 155, 10-19.
10. Grauss, R.W., et al. (2008). Forced myocardin expression enhances the therapeutic effect of human mesenchymal stem cells after transplantation in ischemic mouse hearts. Stem Cells 26, 1083-1093.
11. Hartl, F.U., and Hayer-Hartl, M. (2002). Molecular chaperones in the cytosol: from nascent chain to folded protein. Science 295, 1852-1858.
12. Hino, M., et al. (2000). Small heat shock protein 27 (HSP27) associates with tubulin/microtubules in HeLa cells. Biochem. Biophys. Res. Commun. 271, 164-169.
13. Hoare, M., et al. (2010). Enhanced lipoplex-mediated gene expression in mesenchymal stem cells using reiterated nuclear localization sequence peptides. J. Gene Med. 12, 207-218.
14. Hollander, J.M., et al. (2004). Overexpression of wild-type heat shock protein 27 and a nonphosphorylatable heat shock protein 27 mutant protects against ischemia/reperfusion injury in a transgenic mouse model. Circulation 110, 3544-3552.
15. Kudo, M., et al. (2003). Implantation of bone marrow stem cells reduces the infarction and fibrosis in ischemic mouse heart. J. Mol. Cell. Cardiol. 35, 1113-1119.
16. Laflamme, M.A., et al. (2007). Cardiomyocytes derived from human embryonic stem cells in pro-survival factors enhance function of infarcted rat hearts. Nat. Biotechnol. 25, 1015-1024.
17. Lavoie, J.N., et al. (1993). Modulation of actin microfilament dynamics and fluid phase pinocytosis by phosphorylation of heat shock protein 27. J. Biol. Chem. 268, 24210-24214.
18. Li, W., et al. (2007). Bcl-2 engineered MSCs inhibited apoptosis and improved heart function. Stem Cells 25, 2118-2127.
19. Mangi, A.A., et al. (2003). Mesenchymal stem cells modified with Akt prevent remodeling and restore performance of infarcted hearts. Nat. Med. 9, 1195-1201.
20. McGinley, L., et al. (2011). Lentiviral vector mediated modification of mesenchymal stem cells & enhanced survival in an in vitro model of ischaemia. Stem Cell Res. Ther. 2, 12.
21. McMahon, J.M., et al. (2006). Gene transfer into rat mesenchymal stem cells: a comparative study of viral and nonviral vectors. Stem Cells Dev. 15, 87-96.
22. Mehlen, P., Schulze-Osthoff, K., and Arrigo, A.P. (1996). Small stress proteins as novel regulators of apoptosis. Heat shock protein 27 blocks Fas/APO-1-and staurosporine-induced cell death. J. Biol. Chem. 271, 16510-16514.
23. Mirotsou, M., et al. (2007). Secreted frizzled related protein 2 (Sfrp2) is the key Akt-mesenchymal stem cell-released para-crine factor mediating myocardial survival and repair. Proc. Natl. Acad. Sci. USA 104, 1643-1648.
24. Mosmann, T. (1983). Rapid colorimetric assay for cellular growth and survival: application to proliferation and cyto-toxicity assays. J. Immunol. Methods 65, 55-63.
25. Muller-Ehmsen, J., et al. (2002). Survival and development of neonatal rat cardiomyocytes transplanted into adult myocardium. J. Mol. Cell Cardiol. 34, 107-116.
26. Nagaya, N., et al. (2004). Intravenous administration of mesen-chymal stem cells improves cardiac function in rats with acute myocardial infarction through angiogenesis and myogenesis. Am. J. Physiol. Heart Circ. Physiol. 287, H2670-H2676.
27. Neuhuber, B., et al. (2004). Reevaluation of in vitro differentiation protocols for bone marrow stromal cells: disruption of actin cytoskeleton induces rapid morphological changes and mimics neuronal phenotype. J. Neurosci. Res. 77, 192-204.
28. Neuhuber, B., et al. (2008). Effects of plating density and culture time on bone marrow stromal cell characteristics. Exp. He-matol. 36, 1176-1185.
29. Noiseux, N., et al. (2006). Mesenchymal stem cells over-expressing Akt dramatically repair infarcted myocardium and improve cardiac function despite infrequent cellular fusion or differentiation. Mol. Ther. 14, 840-850.
30. Perin, E.C., et al. (2003). Transendocardial, autologous bone marrow cell transplantation for severe, chronic ischemic heart failure. Circulation 107, 2294-2302.
31. Perng, M.D., et al. (1999). Intermediate filament interactions can be altered by HSP27 and alphaB-crystallin. J. Cell Sci. 112, 2099-2112.
32. Robey, T.E., et al. (2008). Systems approaches to preventing transplanted cell death in cardiac repair. J. Mol. Cell Cardiol. 45, 567-581.
33. Samali, A., and Cotter, T.G. (1996). Heat shock proteins increase resistance to apoptosis. Exp. Cell Res. 223, 163-170.
34. Schachinger, V., et al. (2006a). Improved clinical outcome after intracoronary administration of bone-marrow-derived progenitor cells in acute myocardial infarction: final 1-year results of the REPAIR-AMI trial. Eur. Heart J. 27, 2775-2783.
35. Schachinger, V., et al. (2006b). Intracoronary bone marrow-derived progenitor cells in acute myocardial infarction. N. Engl. J. Med. 355, 1210-1221.
36. Scutt, A., and Bertram, P. (1999). Basic fibroblast growth factor in the presence of dexamethasone stimulates colony formation, expansion, and osteoblastic differentiation by rat bone marrow stromal cells. Calcif. Tissue Int. 64, 69-77.
37. Shujia, J., et al. (2008). Stable therapeutic effects of mesenchymal stem cell-based multiple gene delivery for cardiac repair. Cardiovasc. Res. 77, 525-533.
38. Silva, G.V., et al. (2005). Mesenchymal stem cells differentiate into an endothelial phenotype, enhance vascular density, and improve heart function in a canine chronic ischemia model. Circulation 111, 150-156.
39. Suzuki, K., et al. (2000). Heat shock treatment enhances graft cell survival in skeletal myoblast transplantation to the heart. Circulation 102, III216-III221.
40. Tang, Y.L., et al. (2005). Improved graft mesenchymal stem cell survival in ischemic heart with a hypoxia-regulated heme oxygenase-1 vector. J. Am. Coll. Cardiol. 46, 1339-1350.
41. Toma, C., et al. (2002). Human mesenchymal stem cells differentiate to a cardiomyocyte phenotype in the adult murine heart. Circulation 105, 93-98.
42. Tomita, S., et al. (1999). Autologous transplantation of bone marrow cells improves damaged heart function. Circulation 100, II247-II256.
43. Valina, C., et al. (2007). Intracoronary administration of autolo-gous adipose tissue-derived stem cells improves left ventricular function, perfusion, and remodelling after acute myocardial infarction. Eur. Heart J. 28, 2667-2677.
44. Wang, X., et al. (2009). Hsp20-engineered mesenchymal stem cells are resistant to oxidative stress via enhanced activation of Akt and increased secretion of growth factors. Stem Cells 27, 3021-3031.
45. Wollert, K.C., et al. (2004). Intracoronary autologous bone-marrow cell transfer after myocardial infarction: the BOOST randomised controlled clinical trial. Lancet 364, 141-148.
46. Zhang, M., et al. (2001). Cardiomyocyte grafting for cardiac repair: graft cell death and anti-death strategies. J. Mol. Cell Cardiol. 33, 907-921.
47. Zhang, M., et al. (2007). SDF-1 expression by mesenchymal stem cells results in trophic support of cardiac myocytes after myocardial infarction. FASEB J. 21, 3197-3207.